Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2019 | 09-2018 | 09-2017 | 09-2016 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,562 | -12,537 | -10,385 | -8,296 | -2,902 |
| Depreciation Amortization | 1 | 2 | 3 | 1 | N/A |
| Accounts payable and accrued liabilities | 1,140 | 971 | -307 | 105 | 453 |
| Other Working Capital | 2,196 | 510 | 116 | 668 | 363 |
| Other Operating Activity | -213 | -264 | 2,602 | 1,621 | -299 |
| Operating Cash Flow | $-12,438 | $-11,318 | $-7,971 | $-5,900 | $-2,385 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -2 | N/A | N/A |
| Net Acquisitions | N/A | N/A | N/A | 256 | N/A |
| Investing Cash Flow | $N/A | $N/A | $-2 | $256 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 4,210 | 500 | N/A |
| Common Stock Issued | 11,148 | 17,298 | 6,117 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 556 | 4,763 | 1,510 |
| Financing Cash Flow | $11,148 | $17,298 | $10,883 | $5,263 | $1,510 |
| Beginning Cash Position | 9,184 | 3,204 | 294 | 676 | 1,552 |
| End Cash Position | 7,894 | 9,184 | 3,204 | 294 | 676 |
| Net Cash Flow | $-1,290 | $5,980 | $2,910 | $-382 | $-876 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,438 | -11,318 | -7,971 | -5,900 | -2,385 |
| Capital Expenditure | N/A | N/A | -2 | N/A | N/A |
| Free Cash Flow | -12,438 | -11,318 | -7,973 | -5,900 | -2,385 |